Business Trip
A podcast by Greg Kubin & Matias Serebrinsky - Giovedì
59 Episodio
-
Holy poop! Mental health and the gut (part 2 with Bloom Science)
Pubblicato: 28/09/2023 -
Holy poop! Mental health and the gut (part 1 with Holobiome)
Pubblicato: 14/09/2023 -
Ketamine for OCD: Carolyn Rodriguez (Stanford pt 3)
Pubblicato: 24/08/2023 -
Are psychedelics effective under anesthesia?: Boris Heifets (Stanford pt 2)
Pubblicato: 17/08/2023 -
The Startup Landscape for Expanding Consciousness
Pubblicato: 09/08/2023 -
Stanford Psychedelic Overview: Robert Malenka (Stanford pt 1)
Pubblicato: 20/07/2023 -
Live from Psychedelic Science 2023
Pubblicato: 07/07/2023 -
What VCs Look for in Psychedelic Companies
Pubblicato: 09/06/2023 -
Developing Non-Hallucinogenic Psychedelics: Bryan Roth
Pubblicato: 15/05/2023 -
Behind the Scenes of PsyMed Ventures
Pubblicato: 14/04/2023 -
The 2023 Psychedelic Industry Landscape with Psychedelic Alpha
Pubblicato: 27/02/2023 -
The State of Psychedelics (Part 2): Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)
Pubblicato: 18/01/2023 -
The quest to improve MDMA
Pubblicato: 20/12/2022 -
Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment
Pubblicato: 29/11/2022 -
Perspectives from Christian Angermayer, investor and founder in psychedelics
Pubblicato: 27/10/2022 -
Soltara: an ethical and profitable ayahuasca retreat
Pubblicato: 14/09/2022 -
Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics
Pubblicato: 16/08/2022 -
Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti
Pubblicato: 10/08/2022 -
Microdosing (part 1): James Fadiman and the fundamentals of microdosing
Pubblicato: 03/08/2022 -
How the DEA and FDA will regulate psychedelic medicine
Pubblicato: 24/06/2022
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
